New Releases from NCBI BookshelfDrospirenone (Slynd): CADTH Reimbursement Recommendation: Indication: For conception control in adolescent and adult women [Internet].​Drospirenone (Slynd): CADTH Reimbursement Recommendation: Indication: For conception control in adolescent and adult women [Internet].

By /

CADTH recommends that Slynd should be reimbursed by public drug plans for conception control in adolescent and adult women if certain conditions are met.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top